Home · Peptides · ARA-290
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

ARA-290

THE NERVE HEALER

Cibinetide, PH-BSP

ARA-290 is derived from erythropoietin (EPO) but engineered to provide tissue repair benefits without increasing red blood cell production. It targets a special repair receptor in your nerves and tissues, reducing inflammation and promoting healing. It's particularly promising for diabetic neuropathy and other nerve damage conditions.

ARA-290
ARA-290
ARA-290

ARA-290 Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About ARA-290

◆

Is ARA-290 FDA approved?

No. This profile records ARA-290 as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for ARA-290?

Dose: 4 mg daily.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 4 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this ARA-290 guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Repair Receptor

Activates innate repair receptors without stimulating blood cell production

Nerve Protection

Protects neurons from oxidative stress and promotes regeneration

Anti-Inflammatory

Reduces inflammation through NF-κB inhibition

Blood Sugar

Helps regulate blood glucose and metabolic function

People with diabetic neuropathy
Those suffering from small fiber neuropathy
Chronic pain patients
Type 2 diabetics needing nerve protection
Post-surgical healing support

ARA-290 Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.